Substantia Nigra Echogenicity Signal Correlated with Clinical Features in Patients with Parkinson’s Disease in Xinjiang

Substantia Nigra Echogenicity Signal Correlated with Clinical Features in Patients with Parkinson’s Disease in Xinjiang

Background. Transcranial sonography (TCS) is a noninvasive test that can reveal structural changes in the substantia nigra (SN) in Parkinson’s disease (PD). The purpose of this study was to investigate the relationship between SN signatures and clinical features in PD patients in a multiethnic regio...

Ausführliche Beschreibung

Bibliographische Detailangaben
Hauptverfasser:	Rurui Wei, Yan Zhang, Peishan Li, Zeheng Xu, La Zhang, Yan He, Qinfen Wu, Youcai Shi, Yang Yuan, Abudula Aisha
Format:	Artikel
Sprache:	English
Veröffentlicht:	Hindawi Limited 2023-01-01
Schriftenreihe:	Parkinson's Disease
Online Zugang:	http://dx.doi.org/10.1155/2023/8867546

Ähnliche Einträge

Ferroptosis-related factors in the substantia nigra are associated with Parkinson’s disease
von: Lei Liu, et al.
Veröffentlicht: (2023-09-01)

Substantia nigra alterations in mice modeling Parkinson’s disease
von: I. N. Rozhkova, et al.
Veröffentlicht: (2024-11-01)

Imaging of Substantia Nigra in Parkinson’s Disease: A Narrative Review
von: Paola Feraco, et al.
Veröffentlicht: (2021-06-01)

Sex-Related Abnormalities in Substantia Nigra Lipids in Parkinson’s Disease
von: T. N. Seyfried, et al.
Veröffentlicht: (2018-06-01)

Classification of Parkinson’s Disease in Patch-Based MRI of Substantia Nigra
von: Sayyed Shahid Hussain, et al.
Veröffentlicht: (2023-08-01)

Eyes as Gateways for Environmental Light to the Substantia Nigra: Relevance in Parkinson’s Disease
von: Stefania Romeo, et al.
Veröffentlicht: (2014-01-01)

Diagnostic utility of 7T neuromelanin imaging of the substantia nigra in Parkinson’s disease
von: Dhairya A. Lakhani, et al.
Veröffentlicht: (2024-01-01)

Abnormal Echogenicity of the Substantia Nigra, Raphe Nuclei, and Third-Ventricle Width as Markers of Cognitive Impairment in Parkinsonian Disorders: A Cross-Sectional Study
von: Angela E. P. Bouwmans, et al.
Veröffentlicht: (2016-01-01)

Connectivity-based segmentation of the substantia Nigra in human and its implications in Parkinson's disease.
von: Menke, R, et al.
Veröffentlicht: (2010)

Connectivity-based segmentation of the substantia nigra in human and its implications in Parkinson's disease.
von: Menke, R, et al.
Veröffentlicht: (2010)

Ultrastructural localization of Porphyromonas gingivalis gingipains in the substantia nigra of Parkinson’s disease brains
von: Florian Ermini, et al.
Veröffentlicht: (2024-04-01)

Explorative Combined Lipid and Transcriptomic Profiling of Substantia Nigra and Putamen in Parkinson’s Disease
von: Helena Xicoy, et al.
Veröffentlicht: (2020-08-01)

Advancements in understanding substantia nigra hyperechogenicity via transcranial sonography in Parkinson’s disease and its clinical implications
von: Yuan-yuan Zhang, et al.
Veröffentlicht: (2024-07-01)

Intense exercise increases dopamine transporter and neuromelanin concentrations in the substantia nigra in Parkinson’s disease
von: Bart de Laat, et al.
Veröffentlicht: (2024-02-01)

Altered expression of genes involved in ganglioside biosynthesis in substantia nigra neurons in Parkinson's disease.
von: Jay S Schneider
Veröffentlicht: (2018-01-01)

Dopaminergic neurodegeneration in the substantia nigra is associated with olfactory dysfunction in mice models of Parkinson’s disease
von: Yu Yuan, et al.
Veröffentlicht: (2023-10-01)

Stereotaxic Injection of LPS into Mouse Substantia Nigra
von: Huiming Gao
Veröffentlicht: (2012-04-01)

Transcranial Sonography of the Substantia Nigra for the Differential Diagnosis of Parkinson’s Disease and Other Movement Disorders: A Meta-Analysis
von: Yan-Liang Mei, et al.
Veröffentlicht: (2021-01-01)

MRI characteristics of the substantia nigra in Parkinson's disease: a combined quantitative T1 and DTI study.
von: Menke, R, et al.
Veröffentlicht: (2009)

Nanoscale synchrotron x-ray analysis of intranuclear iron in melanised neurons of Parkinson’s substantia nigra
von: Jake Brooks, et al.
Veröffentlicht: (2024-08-01)

Impact of Combined Subthalamic Nucleus and Substantia Nigra Stimulation on Neuropsychiatric Symptoms in Parkinson’s Disease Patients
von: U. Hidding, et al.
Veröffentlicht: (2017-01-01)

Diffusion Kurtosis Imaging of Substantia Nigra Is a Sensitive Method for Early Diagnosis and Disease Evaluation in Parkinson’s Disease
von: Guohua Zhang, et al.
Veröffentlicht: (2015-01-01)

SYNAPTIC AND DENDRITIC CORRELATES OF HETEROGENEOUS ACTIVITY OF DOPAMINERGIC NEURONS IN THE SUBSTANTIA NIGRA PARS COMPACTA
von: Henny, P, et al.
Veröffentlicht: (2011)

Hyperechogenicity of the Substantia Nigra in Parkinson’s Disease: Insights from Two Brothers with Markedly Different Disease Durations
von: Julie M. Hall, et al.
Veröffentlicht: (2017-01-01)

Identification of Hub Genes and Potential Molecular Pathogenesis in Substantia Nigra in Parkinson’s Disease via Bioinformatics Analysis
von: Yunan Zhou, et al.
Veröffentlicht: (2023-01-01)

Utility of Combining Transcranial Sonography and MIBG Myocardial Scintigraphy to Evaluate Substantia Nigra in Patients with Parkinson’s Disease
von: Heisuke Mizukami, et al.
Veröffentlicht: (2024-05-01)

Integrative analysis of gene expression profiles of substantia nigra identifies potential diagnosis biomarkers in Parkinson's disease
von: Junming Huang, et al.
Veröffentlicht: (2024-01-01)

Picornavirus May Be Linked to Parkinson’s Disease through Viral Antigen in Dopamine-Containing Neurons of Substantia Nigra
von: Bo Niklasson, et al.
Veröffentlicht: (2022-03-01)

Proteomic Characterization of Synaptosomes from Human Substantia Nigra Indicates Altered Mitochondrial Translation in Parkinson’s Disease
von: Sarah Plum, et al.
Veröffentlicht: (2020-12-01)

COMPARISON OF LOCUS COERULEUS PATHOLOGY WITH SUBSTANTIA NIGRA PATHOLOGY IN A PROGRESSIVE MONKEY MODEL OF PARKINSON'S DISEASE
von: Megan Carrillo Díaz De Argandoña, et al.
Veröffentlicht: (2023-10-01)

Primary cilia in Parkinson’s disease: summative roles in signaling pathways, genes, defective mitochondrial function, and substantia nigra dopaminergic neurons
von: Zijiao Tian, et al.
Veröffentlicht: (2024-09-01)

Behavioral effects of aminochrome and dopachrome injected in the rat substantia nigra.
von: Díaz-Véliz, G, et al.
Veröffentlicht: (2002)

Infiltrating peripheral monocyte TREM-1 mediates dopaminergic neuron injury in substantia nigra of Parkinson’s disease model mice
von: Wei Song, et al.
Veröffentlicht: (2025-01-01)

Sex differences for clinical correlates of substantia nigra neuron loss in people with Lewy body pathology
von: Ece Bayram, et al.
Veröffentlicht: (2024-01-01)

A Single-Cell Atlas of the Substantia Nigra Reveals Therapeutic Effects of Icaritin in a Rat Model of Parkinson’s Disease
von: Hao Wu, et al.
Veröffentlicht: (2024-09-01)

Co-Expression of Nogo-A in Dopaminergic Neurons of the Human Substantia Nigra Pars Compacta Is Reduced in Parkinson’s Disease
von: Gian-Carlo Eyer, et al.
Veröffentlicht: (2021-11-01)

An investigation of neuromelanin distribution in substantia nigra and locus coeruleus in patients with Parkinson’s disease using neuromelanin-sensitive MRI
von: Qiang Liu, et al.
Veröffentlicht: (2023-08-01)

TREM-1 mediates interaction between substantia nigra microglia and peripheral neutrophils
von: Tong Shen, et al.
Veröffentlicht: (2024-01-01)

Behavioural response to bilateral injections of substance P into the substantia nigra of the rat.
von: Kelley, A, et al.
Veröffentlicht: (1978)

ISOLATION AND CHARACTERIZATION OF SINGLE NEURONS FROM GUINEA-PIG SUBSTANTIA-NIGRA
von: Hainsworth, A, et al.
Veröffentlicht: (1990)